Neurotech’s NTI164 Shows Promise in Autism Trial

Neurotech International Ltd. (AU:NTI) has released an update. Neurotech International Ltd reports promising results from its Phase II/III clinical trial for Autism …

Comments

  • No comments yet.
  • Add a comment